NNVC NanoViricides, Inc.

$1.26

NanoViricides, Inc. (NNVC) is expected to report earnings on December 28, 2026, during market hours. The consensus earnings estimate is a loss of $0.10 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -12.5% since its last earnings release on September 28, 2026.

NanoViricides Beat Consensus Estimates
Monday, September 28, 2026 · 12:00 AM ET
Earnings Date
1st Quarter, Sep 2026
Dec 28
Monday · Market Hours
Earnings Whisper
-
vs ($0.10)
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $1.35

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About NanoViricides, Inc.

Nanoviricides Inc a development stage nano-biopharmaceutical company, engages in the discovery, development, and commercialization of anti-viral therapeutics primarily in the United States.

Sector

Healthcare

Industry

Biotechnology

Charts powered in part by Lightweight Charts™ by TradingView.